MedPath

University Medical Center Groningen

University Medical Center Groningen logo
🇳🇱Netherlands
Ownership
Private
Established
1614-01-01
Employees
10K
Market Cap
-
Website
https://www.umcg.nl

Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II

Phase 2
Recruiting
Conditions
CIN3
HPV 16 Infection
Cervical Intraepithelial Neoplasia Grade 3
Cervical Intraepithelial Neoplasia
Interventions
Biological: Vvax001 therapeutic cancer vaccine
First Posted Date
2023-08-29
Last Posted Date
2023-08-29
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
18
Registration Number
NCT06015854
Locations
🇳🇱

University Medical Center Groningen (UMCG), Groningen, Netherlands

Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial

Not Applicable
Recruiting
Conditions
Hallucinations, Verbal Auditory
Interventions
Other: Treatment as usual
Behavioral: VR-VOICES
First Posted Date
2023-08-28
Last Posted Date
2024-01-19
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
112
Registration Number
NCT06013748
Locations
🇳🇱

GGZ Drenthe, Assen, Netherlands

🇳🇱

University Medical Center Groningen, Groningen, Netherlands

🇳🇱

Lentis, Groningen, Netherlands

Safety and Feasibility of Immuno-OCT

Not Applicable
Not yet recruiting
Conditions
Colon Carcinoma
Barrett Esophagus
Gastrointestinal Dysplasia
Interventions
First Posted Date
2023-08-23
Last Posted Date
2024-03-20
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
15
Registration Number
NCT06008522

68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19

Completed
Conditions
Post-Acute COVID-19 Syndrome
Post-Acute COVID-19 Infection
Pulmonary Fibrosis
Post-Acute COVID-19
First Posted Date
2023-08-08
Last Posted Date
2024-05-21
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
18
Registration Number
NCT05981885
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults

Phase 4
Not yet recruiting
Conditions
Thyroid Carcinoma
Renal Cell Carcinoma
Breast Carcinoma
Ovarian Carcinoma
Endometrium Carcinoma
Interventions
First Posted Date
2023-07-18
Last Posted Date
2023-11-29
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
30
Registration Number
NCT05949424
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study

Not Applicable
Recruiting
Conditions
Breast Cancer Invasive
Breast Cancer
Interventions
Procedure: Fluorescence guided detection of tumor positive margins.
First Posted Date
2023-07-11
Last Posted Date
2024-04-19
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
70
Registration Number
NCT05939310
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

🇳🇱

Martini Ziekenhuis, Groningen, Netherlands

Lower Extremity Amputations in Persons With Diabetes Mellitus in the Netherlands

Active, not recruiting
Conditions
Lower Extremity Amputations
Diabetes Mellitus
Interventions
Procedure: lower extremity amputation
First Posted Date
2023-07-11
Last Posted Date
2023-07-11
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
2808
Registration Number
NCT05939271
Locations
🇳🇱

L. Rosien, Zwolle, Overijssel, Netherlands

Flash Mob Study With Regard to Travel Willingness Among Patients With Cancer

Completed
Conditions
Cancer
Interventions
Other: Survey about travel willingness regarding cancer treatment and follow-up
First Posted Date
2023-07-11
Last Posted Date
2023-07-11
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
5000
Registration Number
NCT05940753
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action

Not Applicable
Recruiting
Conditions
COPD
Interventions
Device: PEP-buddy
First Posted Date
2023-07-10
Last Posted Date
2025-03-27
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
25
Registration Number
NCT05938738
Locations
🇳🇱

UMCG, Groningen, Netherlands

Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)

Phase 1
Recruiting
Conditions
Glioblastoma
High-grade Glioma
Interventions
First Posted Date
2023-07-03
Last Posted Date
2023-07-03
Lead Sponsor
University Medical Center Groningen
Target Recruit Count
21
Registration Number
NCT05929456
Locations
🇳🇱

UMCG, Groningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath